Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:e98

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rus, H.
Right arrow Articles by Niculescu, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rus, H.
Right arrow Articles by Niculescu, F.
Related Collections
Right arrow Catheter-based coronary interventions: stents
Right arrow Chronic ischemic heart disease

(Circulation. 1999;100:e98.)
© 1999 American Heart Association, Inc.


Circulation Electronic Pages

Inflammatory Response in Unstable Angina

Horea Rus, MD, PhD; Florin Niculescu, MD, PhD

From University of Maryland, School of Medicine, Department of Pathology, Baltimore, Md


*    To the Editor:
 
We read with great interest the article by Liuzzo et al1 regarding the systemic inflammatory markers associated with unstable angina. We would like to also emphasize the fact that the increase of inflammatory markers is present not only in the circulation, as shown in their article, but also in the arterial atherosclerotic wall itself. We2 3 have previously measured C-reactive protein (CRP) and interleukin-6 (IL-6) levels eluted from human aortic wall with atherosclerosis. High levels of CRP were present in fatty-streak lesions and uncomplicated fibrous plaques.2 Low levels of CRP were found only in a few normal areas. As measured by ELISA, IL-6 levels were statistically significantly higher in the fibrous plaques than in normal areas. IL-6 was localized by immunohistochemistry as both intracellular and extracellular deposits. Compared with its serum levels, IL-6 was 200-fold higher in the atherosclerotic wall than in serum.3 The accumulation of CRP and IL-6 in the atherosclerotic wall is a marker for a local inflammatory process.

Our data suggest that both local production and the accumulation of proteins from plasma may contribute to the increased levels observed in atherosclerotic lesions.2 3 Serum amyloid A (SAA) is also present in the atherosclerotic wall.4 Arterial vessel injury is followed by the release of soluble arterial proteins in circulation. Such constant release of IL-6 from vulnerable atherosclerotic plaques in patients with unstable angina may account for the increased serum basal levels seen by Liuzzo et al in their study.1

At 6 hours after PTCA, IL-6 levels were twice the basal . . . [Full Text of this Article]